日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy

循环肿瘤DNA的纵向分析揭示了转移性前列腺癌在连续治疗过程中的演变动态

Zhao, Yuehui; Ramesh, Naveen; Xu, Ping; Sei, Emi; Hu, Min; Bai, Shanshan; Troncoso, Patricia; Aparicio, Ana M; Logothetis, Christopher J; Corn, Paul G; Navin, Nicholas E; Zurita, Amado J

A Modular Trial of Androgen Signaling Inhibitor Combinations Testing a Risk-Adapted Strategy in Patients with Metastatic Castration-Resistant Prostate Cancer.

一项针对转移性去势抵抗性前列腺癌患者的风险适应性策略的雄激素信号抑制剂组合模块化试验

Aparicio Ana M, Tidwell Rebecca S S, Yadav Shalini S, Chen Jiun-Sheng, Zhang Miao, Liu Jingjing, Guo Shuai, Pilié Patrick G, Yu Yao, Song Xingzhi, Vundavilli Haswanth, Jindal Sonali, Zhu Keyi, Viscuse Paul V, Lebenthal Justin M, Hahn Andrew W, Soundararajan Rama, Corn Paul G, Zurita-Saavedra Amado, Subudhi Sumit K, Zhang Jianhua, Wang Wenyi, Huff Chad, Troncoso Patricia, Allison James P, Sharma Padmanee, Logothetis Christopher J

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

专家对去势敏感性前列腺癌治疗争议的看法:叙述性回顾及首届美国前列腺癌大会报告(第一部分)

Crawford, E David; Bryce, Alan H; Hussain, Maha H; Agarwal, Neeraj; Beltran, Himisha; Cooperberg, Matthew R; Petrylak, Daniel P; Shore, Neal; Spratt, Daniel E; Tagawa, Scott T; Antonarakis, Emmanuel S; Aparicio, Ana M; Armstrong, Andrew J; Boike, Thomas P; Calais, Jeremie; Carducci, Michael A; Chapin, Brian F; Cookson, Michael S; Davis, John W; Dorff, Tanya; Eggener, Scott E; Feng, Felix Y; Gleave, Martin; Higano, Celestia; Iagaru, Andrei; Morgans, Alicia K; Morris, Michael; Murray, Katie S; Poage, Wendy; Rettig, Matthew B; Sartor, Oliver; Scher, Howard I; Sieber, Paul; Small, Eric; Srinivas, Sandy; Yu, Evan Y; Zhang, Tian; Koo, Phillip J

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

专家对转移性去势抵抗性前列腺癌治疗争议的看法:叙述性回顾及首届美国前列腺癌大会报告(第二部分)

Bryce, Alan H; Crawford, E David; Agarwal, Neeraj; Hussain, Maha H; Beltran, Himisha; Cooperberg, Matthew R; Petrylak, Daniel P; Shore, Neal; Spratt, Daniel E; Tagawa, Scott T; Antonarakis, Emmanuel S; Aparicio, Ana M; Armstrong, Andrew J; Boike, Thomas P; Calais, Jeremie; Carducci, Michael A; Chapin, Brian F; Cookson, Michael S; Davis, John W; Dorff, Tanya; Eggener, Scott E; Feng, Felix Y; Gleave, Martin; Higano, Celestia; Iagaru, Andrei; Morgans, Alicia K; Morris, Michael; Murray, Katie S; Poage, Wendy; Rettig, Matthew B; Sartor, Oliver; Scher, Howard I; Sieber, Paul; Small, Eric; Srinivas, Sandy; Yu, Evan Y; Zhang, Tian; Koo, Phillip J

Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

晚期前列腺癌患者的管理。第一部分:中/高危及局部晚期疾病、生化复发和激素治疗的副作用:2022年晚期前列腺癌共识会议报告

Gillessen, Silke; Bossi, Alberto; Davis, Ian D; de Bono, Johann; Fizazi, Karim; James, Nicholas D; Mottet, Nicolas; Shore, Neal; Small, Eric; Smith, Mathew; Sweeney, Christopher; Tombal, Bertrand; Antonarakis, Emmanuel S; Aparicio, Ana M; Armstrong, Andrew J; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Blanchard, Pierre; Briganti, Alberto; Bristow, Rob G; Bulbul, Muhammad; Caffo, Orazio; Castellano, Daniel; Castro, Elena; Cheng, Heather H; Chi, Kim N; Chowdhury, Simon; Clarke, Caroline S; Clarke, Noel; Daugaard, Gedske; De Santis, Maria; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Efstathiou, Jason; Ngozi Ekeke, Onyeanunam; Evans, Christopher P; Fanti, Stefano; Feng, Felix Y; Fonteyne, Valerie; Fossati, Nicola; Frydenberg, Mark; George, Daniel; Gleave, Martin; Gravis, Gwenaelle; Halabi, Susan; Heinrich, Daniel; Herrmann, Ken; Higano, Celestia; Hofman, Michael S; Horvath, Lisa G; Hussain, Maha; Jereczek-Fossa, Barbara Alicja; Jones, Robert; Kanesvaran, Ravindran; Kellokumpu-Lehtinen, Pirkko-Liisa; Khauli, Raja B; Klotz, Laurence; Kramer, Gero; Leibowitz, Raya; Logothetis, Christopher J; Mahal, Brandon A; Maluf, Fernando; Mateo, Joaquin; Matheson, David; Mehra, Niven; Merseburger, Axel; Morgans, Alicia K; Morris, Michael J; Mrabti, Hind; Mukherji, Deborah; Murphy, Declan G; Murthy, Vedang; Nguyen, Paul L; Oh, William K; Ost, Piet; O'Sullivan, Joe M; Padhani, Anwar R; Pezaro, Carmel; Poon, Darren M C; Pritchard, Colin C; Rabah, Danny M; Rathkopf, Dana; Reiter, Robert E; Rubin, Mark A; Ryan, Charles J; Saad, Fred; Pablo Sade, Juan; Sartor, Oliver A; Scher, Howard I; Sharifi, Nima; Skoneczna, Iwona; Soule, Howard; Spratt, Daniel E; Srinivas, Sandy; Sternberg, Cora N; Steuber, Thomas; Suzuki, Hiroyoshi; Sydes, Matthew R; Taplin, Mary-Ellen; Tilki, Derya; Türkeri, Levent; Turco, Fabio; Uemura, Hiroji; Uemura, Hirotsugu; Ürün, Yüksel; Vale, Claire L; van Oort, Inge; Vapiwala, Neha; Walz, Jochen; Yamoah, Kosj; Ye, Dingwei; Yu, Evan Y; Zapatero, Almudena; Zilli, Thomas; Omlin, Aurelius

Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events

在出现中度至重度免疫相关不良事件后,泌尿生殖系统癌症患者再次接受免疫检查点疗法治疗后,疗效持久。

Siddiqui, Bilal A; Gheeya, Jinesh S; Goswamy, Rohit; Bathala, Tharakeswara K; Surasi, Devaki Shilpa; Gao, Jianjun; Shah, Amishi; Campbell, Matthew T; Msaouel, Pavlos; Goswami, Sangeeta; Wang, Jennifer; Zurita, Amado J; Jonasch, Eric; Corn, Paul G; Aparicio, Ana M; Siefker-Radtke, Arlene O; Sharma, Padmanee; Subudhi, Sumit K; Tannir, Nizar

Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

在未接受化疗的转移性去势抵抗性前列腺癌患者中,CTLA-4 和 PD-L1 联合阻断与骨微环境中髓系和中性粒细胞免疫亚群的增加有关。

Subudhi, Sumit K; Siddiqui, Bilal A; Aparicio, Ana M; Yadav, Shalini S; Basu, Sreyashi; Chen, Hong; Jindal, Sonali; Tidwell, Rebecca S S; Varma, Ashwin; Logothetis, Christopher J; Allison, James P; Corn, Paul G; Sharma, Padmanee

Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors

评估利用技术手段监测患者报告结果以检测和治疗与免疫检查点抑制剂相关的毒性反应

Msaouel, Pavlos; Oromendia, Clara; Siefker-Radtke, Arlene O; Tannir, Nizar M; Subudhi, Sumit K; Gao, Jianjun; Wang, Yinghong; Siddiqui, Bilal A; Shah, Amishi Y; Aparicio, Ana M; Campbell, Matthew T; Zurita, Amado J; Shaw, Leah K; Lopez, Lidia P; McCord, Heather; Chakraborty, Sandip N; Perales, Jacqueline; Lu, Cong; Van Alstine, Michael L; Elashoff, Michael; Logothetis, Christopher

Phase II study of the histone deacetylase inhibitor vorinostat (Suberoylanilide Hydroxamic Acid; SAHA) in recurrent or metastatic transitional cell carcinoma of the urothelium - an NCI-CTEP sponsored: California Cancer Consortium trial, NCI 6879

组蛋白去乙酰化酶抑制剂伏立诺他(辛酰苯胺异羟肟酸;SAHA)治疗复发性或转移性尿路上皮移行细胞癌的II期研究——一项由美国国家癌症研究所-癌症治疗扩展计划(NCI-CTEP)资助的加州癌症联盟试验,NCI 6879

Quinn, David I; Tsao-Wei, Denice D; Twardowski, Przemyslaw; Aparicio, Ana M; Frankel, Paul; Chatta, Gurkamal; Wright, John J; Groshen, Susan G; Khoo, Stella; Lenz, Heinz-Josef; Lara, Primo N; Gandara, David R; Newman, Edward

The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development

MD安德森前列腺癌患者来源异种移植模型系列(MDA PCa PDX)能够捕捉前列腺癌的分子特征,并促进基于分子标志物的治疗研发。

Palanisamy, Nallasivam; Yang, Jun; Shepherd, Peter D A; Li-Ning-Tapia, Elsa M; Labanca, Estefania; Manyam, Ganiraju C; Ravoori, Murali K; Kundra, Vikas; Araujo, John C; Efstathiou, Eleni; Pisters, Louis L; Wan, Xinhai; Wang, Xuemei; Vazquez, Elba S; Aparicio, Ana M; Carskadon, Shannon L; Tomlins, Scott A; Kunju, Lakshmi P; Chinnaiyan, Arul M; Broom, Bradley M; Logothetis, Christopher J; Troncoso, Patricia; Navone, Nora M